Shacham-Shmueli E - Search Results

1

Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.

Margalit O, Harmsen WS, Shacham-Shmueli E, Voss MM, Boursi B, Wagner AD, Cohen R, Olswold CL, Saltz LB, Goldstein DA, Hurwitz H, Tebbutt NC, Kabbinavar FF, Adams RA, Chibaudel B, Grothey A, Yoshino T, Zalcberg J, de Gramont A, Shi Q, Lenz HJ. Margalit O, et al. Among authors: shacham shmueli e. Eur J Cancer. 2023 Nov;194:113339. doi: 10.1016/j.ejca.2023.113339. Epub 2023 Sep 28. Eur J Cancer. 2023. PMID: 37813779 No abstract available.

2

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Margalit O, et al. Eur J Cancer. 2018 May;94:1-5. doi: 10.1016/j.ejca.2018.01.112. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29502035

3

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Margalit O, et al. Eur J Cancer. 2018 Jun;96:105-110. doi: 10.1016/j.ejca.2018.03.022. Epub 2018 Apr 24. Eur J Cancer. 2018. PMID: 29698932

4

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.

Goey KKH, Sørbye H, Glimelius B, Adams RA, André T, Arnold D, Berlin JD, Bodoky G, de Gramont A, Díaz-Rubio E, Eng C, Falcone A, Grothey A, Heinemann V, Hochster HS, Kaplan RS, Kopetz S, Labianca R, Lieu CH, Meropol NJ, Price TJ, Schilsky RL, Schmoll HJ, Shacham-Shmueli E, Shi Q, Sobrero AF, Souglakos J, Van Cutsem E, Zalcberg J, van Oijen MGH, Punt CJA, Koopman M. Goey KKH, et al. Eur J Cancer. 2018 Sep;100:35-45. doi: 10.1016/j.ejca.2018.05.010. Epub 2018 Jun 22. Eur J Cancer. 2018. PMID: 29936065

5

Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.

Cohn E, Lurie I, Yang YX, Bilker WB, Haynes K, Mamtani R, Shacham-Shmueli E, Margalit O, Boursi B. Cohn E, et al. J Trauma Stress. 2018 Dec;31(6):919-926. doi: 10.1002/jts.22345. Epub 2018 Dec 6. J Trauma Stress. 2018. PMID: 30520529

6

Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma.

Boursi B, Werner TJ, Gholami S, Margalit O, Baruch E, Markel G, Eshet Y, Houshmand S, Shacham-Shmueli E, Mitchell TC, Mamtani R, Alavi A, Yang YX. Boursi B, et al. Melanoma Res. 2019 Jun;29(3):318-321. doi: 10.1097/CMR.0000000000000566. Melanoma Res. 2019. PMID: 30557217

7

Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.

Margalit O, Mamtani R, Kopetz S, Yang YX, Lawrence YR, Abu-Gazala S, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Margalit O, et al. Oncologist. 2019 Aug;24(8):e671-e676. doi: 10.1634/theoncologist.2018-0333. Epub 2019 Jan 29. Oncologist. 2019. PMID: 30696723 Free PMC article.

8

Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?

Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Margalit O, et al. Mol Clin Oncol. 2019 May;10(5):555-559. doi: 10.3892/mco.2019.1825. Epub 2019 Mar 14. Mol Clin Oncol. 2019. PMID: 30967950 Free PMC article.

9

Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.

Margalit O, Mamtani R, Lawrence YR, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B. Margalit O, et al. Clin Colorectal Cancer. 2019 Sep;18(3):226-230.e2. doi: 10.1016/j.clcc.2019.04.004. Epub 2019 Apr 13. Clin Colorectal Cancer. 2019. PMID: 31097386

10

Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.

Margalit O, Shacham-Shmueli E, Lawrence YR, Yang YX, Reiss KA, Golan T, Mamtani R, Halpern N, Aderka D, Giantonio B, Boursi B. Margalit O, et al. Clin Colorectal Cancer. 2019 Sep;18(3):e300-e307. doi: 10.1016/j.clcc.2019.06.001. Epub 2019 Jun 26. Clin Colorectal Cancer. 2019. PMID: 31324478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters